SCHEMBL20109954

SCHEMBL20109954

c1ccc(-c2c3ccccc3c(-c3cccc4oc5ccc(-c6ccc(-c7ccccc7-c7ccc8ccccc8c7)cc6)cc5c34)c3ccccc23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.39
▸ PLA2G4A P47712 4/20 0.39
▸ PLA2G10 O15496 1/20 0.38
▸ PGR P06401 1/20 0.37
▸ GPR84 Q9NQS5 1/20 0.37
▸ ANO1 Q5XXA6 1/20 0.37
▸ CASP3 P42574 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ HSD17B1 P14061 1/20 0.35
▸ HSD17B2 P37059 1/20 0.35
▸ HDAC4 P56524 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ FYN P06241 1/20 0.34
▸ MAPK3 P27361 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27010125 0.96 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL27331711 0.95 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL24292823 0.94 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL27010159 0.93 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL23426624 0.93 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL25126762 0.92 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL27010063 0.92 PLA2G2A (0.43) PLA2G2APLA2G4APLA2G10PGRANO1
SCHEMBL20109943 0.92 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10ABCG2WEE1
SCHEMBL24173706 0.91 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10PGRGPR84
SCHEMBL27301737 0.90 HDAC4 (0.39) GPR84HSD17B1HSD17B2HDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023359-A1 ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER SFC CO., LTD. (KR) 2024-01-18 — — US disclosed
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME SFC CO., LTD. (KR) 2023-11-16 — — US disclosed
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME SFC CO., LTD. (KR) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230371376-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME PPOX, MAP1LC3A, VDAC2 PLA2G2A 1893/4885PLA2G4A 1054/4885PLA2G10 857/4885
US-20180123055-A1 COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME CYP1B1, CYP1A1, CRY2 PLA2G2A 1057/4885PLA2G4A 1308/4885PLA2G10 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback